ALPS ADVISORS INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 200 filers reported holding NEKTAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2019$376,000
+0.5%
10,572
-5.0%
0.00%0.0%
Q1 2019$374,000
-47.1%
11,128
-48.3%
0.00%
-40.0%
Q4 2018$707,000
-46.3%
21,511
-0.4%
0.01%
-44.4%
Q3 2018$1,317,000
+490.6%
21,602
+931.6%
0.01%
+350.0%
Q1 2018$223,000
-94.0%
2,094
-98.6%
0.00%
-92.3%
Q3 2017$3,695,000
+35.0%
153,958
+9.9%
0.03%
+36.8%
Q2 2017$2,738,000140,0430.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2017
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders